Barchart Research What to Expect from ICLR Earnings ICLR Generated May 5, 2026 Current Price $121.32 EPS Estimate $$2.80 Consensus Rating Moderate Buy Average Move 8.86% Icon Plc Reports Earnings After...
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that the Audit Committee of the Board of Directors has completed its investigation into certain of the Company’s...
Barchart Research What to Expect from ICLR Earnings ICLR Generated April 28, 2026 Current Price $102.49 EPS Estimate $$2.99 Consensus Rating Moderate Buy Average Move 8.86% ICON's Accounting Cleanup: Can...
Barchart Research What to Expect from ICLR Earnings ICLR Generated March 31, 2026 Current Price $110.66 EPS Estimate $$3.16 Consensus Rating Moderate Buy Average Move 8.86% ICON's April Thirtieth Verdict:...
Partnership will integrate ICON’s clinical trial technology with Advarra’s purpose-built system for research sites, embedded across a broad, deeply established global network. ...
New York, New York--(Newsfile Corp. - March 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company (NASDAQ: ICLR) ("ICON Public Limited...
New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ:...
NEW YORK , March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). Such investors are advised to contact...
New York, New York--(Newsfile Corp. - March 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ:...